capmatinib 150 MG Oral Tablet
- RxCUI
- 2362234
- RxNorm name
- capmatinib 150 MG Oral Tablet
- Display name
- capmatinib 150 MG Oral Tablet
- Full name
- capmatinib 150 MG Oral Tablet
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:56
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| TABRECTA | CAPMATINIB | Novartis Pharmaceuticals Corporation | 455892c3-d144-4ba8-9ab4-79cabff9876d | 2025-12-15 | Warnings, Adverse reactions | 2362234 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 455892c3-d144-4ba8-9ab4-79cabff9876d | capmatinib 150 MG Oral Tablet | PSN | 17 | These highlights do not include all the information needed to use TABRECTA safely and effectively. See full prescribing information for TABRECTA. TABRECTA ® (capmatinib) tablets, for oral use Initial U.S. Approval: 2020 | 20251215 |
| 455892c3-d144-4ba8-9ab4-79cabff9876d | capmatinib 150 MG (capmatinib HCl 176.55 MG) Oral Tablet | SY | 17 | These highlights do not include all the information needed to use TABRECTA safely and effectively. See full prescribing information for TABRECTA. TABRECTA ® (capmatinib) tablets, for oral use Initial U.S. Approval: 2020 | 20251215 |
| 455892c3-d144-4ba8-9ab4-79cabff9876d | capmatinib 150 MG Oral Tablet | SCD | 17 | These highlights do not include all the information needed to use TABRECTA safely and effectively. See full prescribing information for TABRECTA. TABRECTA ® (capmatinib) tablets, for oral use Initial U.S. Approval: 2020 | 20251215 |